Treatment and prognosis of secondary glaucoma in Fuchs' heterochromic iridocyclitis

Ellen La Hey, J de Vries, C T Langerhorst, G S Baarsma, A Kijlstra

Research output: Contribution to journalArticleResearchpeer-review


After reviewing the records of 111 patients with Fuchs' heterochromic iridocyclitis, we studied the therapy and prognosis of secondary glaucoma in 30 of these 111 patients (27%) who had glaucoma or could be considered glaucoma suspects. Maximal medical therapy was unsuccessful in 22 of the 30 patients (73%). Surgical intervention (mostly trabeculectomies, half with 5-fluorouracil) successfully controlled intraocular pressure (< or = 21 mm Hg with or without medication) in 13 of the 18 operated-on patients (72%) after a mean follow-up of 26 months. All successfully operated-on patients retained a visual acuity of 20/80 or better. We had favorable results, possibly because of modern surgical techniques (use of 5-fluorouracil, sodium hyaluronate) or earlier surgical intervention, or both.

Original languageEnglish
Pages (from-to)327-40
Number of pages14
JournalAmerican Journal of Ophthalmology
Issue number3
Publication statusPublished - 15 Sept 1993


  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Glaucoma/drug therapy
  • Humans
  • Iridocyclitis/complications
  • Laser Therapy
  • Male
  • Middle Aged
  • Prognosis
  • Trabeculectomy/adverse effects
  • Treatment Outcome


Dive into the research topics of 'Treatment and prognosis of secondary glaucoma in Fuchs' heterochromic iridocyclitis'. Together they form a unique fingerprint.

Cite this